The corporate duty of care is a fiduciary obligation that requires directors and senior officers to make informed, attentive decisions when running a company, using the diligence a reasonably prudent person would apply in a similar role. It doesn’t demand correct outcomes. It demands that you do the work: read the materials, ask the questions, build systems that catch problems, and deliberate before you vote. Falling short can expose a director personally, but between the high liability threshold and the layered protections most companies have in place, successful claims are rare.
Who Owes This Duty
Every member of the board owes it, whether they are inside directors who also work for the company or independent outside directors who show up for quarterly meetings. Senior officers owe it too, including the CEO, CFO, general counsel, and other executives who make significant operational decisions. Shareholders do not, because they lack direct control over corporate assets and strategy.
The scope is the same regardless of how involved a director is day to day. An outside director who attends four meetings a year is held to the same standard as an inside director walking the halls every morning. That catches some people off guard, particularly independent directors who see their role as advisory. Every vote you cast and every report you choose not to read carries the same legal weight.
The Standard Directors Must Meet
Under Section 8.30 of the Model Business Corporation Act, adopted in some form by a majority of states, a director must act in good faith and in a manner they reasonably believe to be in the best interests of the corporation. When gathering information or monitoring the business, they must use the care that a person in a similar position would reasonably consider appropriate under the circumstances. This is an objective standard, measured against a hypothetical competent peer rather than against your own personal habits.
The standard evaluates process, not results. A board that carefully studied a proposed acquisition, consulted advisors, and deliberated over several meetings won’t face liability just because the deal soured. The question is whether you got informed before you decided.
Gross Negligence Is the Liability Threshold
Courts don’t impose liability for ordinary mistakes. A breach of the duty of care requires gross negligence, meaning conduct so far below reasonable standards that it amounts to reckless indifference to the company and its shareholders. An honest error in judgment doesn’t clear that bar. A board that approves a billion-dollar sale in two hours without looking at any financial data is a different story.
Courts set the threshold deliberately high. Business decisions involve real uncertainty, and second-guessing every board vote with the benefit of hindsight would paralyze corporate governance. The gross negligence standard leaves room for informed risk-taking while still holding directors accountable for genuinely reckless behavior.
What Informed Decision-Making Looks Like
The practical heart of the duty is getting informed before you vote. On major transactions like mergers, acquisitions, or large contracts, directors must review the relevant financial data, understand the risks, and ask hard questions. That means reading the materials distributed before the meeting rather than showing up and voting with the majority. Courts examine the record closely: board minutes, documents circulated in advance, and how much time the board actually spent deliberating.
Directors are not expected to independently investigate every technical detail. Corporate statutes expressly allow them to rely in good faith on reports and opinions from officers, employees, outside accountants, lawyers, and other professionals, provided the director reasonably believes the expert is competent in that area and was selected with reasonable care.1Delaware Code Online. Delaware Code Title 8, Chapter 1, Subchapter IV The MBCA contains a nearly identical provision. Reliance has limits, though. If a CEO gives a vague oral summary of a deal with no supporting documentation, rubber-stamping that presentation doesn’t count as informed decision-making.
Ongoing Oversight and the Caremark Standard
The duty applies between votes, not just at them. Directors have a continuous obligation to monitor operations, legal compliance, and risk exposure. That means putting internal reporting systems in place and actually paying attention to what those systems produce. A board that sets up compliance structures and reviews their output is meeting this obligation. A board that never asks about compliance at all is not.
The legal framework here comes from the 1996 Delaware decision In re Caremark International, which set what remains one of the hardest claims to win in corporate law. A plaintiff must show either that directors completely failed to implement any reporting or compliance system, or that they had one in place but consciously ignored what it was telling them.2Justia Law. Marchand v. Barnhill The word “consciously” is doing heavy lifting. A board that receives reports and occasionally misses a red flag looks very different, legally, from a board that never bothered to build a reporting system at all.
The 2019 Marchand v. Barnhill case showed that Caremark has teeth when facts are extreme enough. Blue Bell Creameries, an ice cream company, had no board committee responsible for food safety, no protocol requiring management to deliver food safety reports to the board, and no regular board discussion of food safety compliance. After a listeria outbreak caused serious harm, the Delaware Supreme Court held these facts supported a viable claim that the board had utterly failed its oversight duty.2Justia Law. Marchand v. Barnhill The lesson is straightforward. If your company faces a central regulatory risk, the board needs a visible, documented system for monitoring it.
The Business Judgment Rule
The business judgment rule is the main shield protecting directors when decisions turn out badly. It creates a legal presumption that directors acted in good faith, on an informed basis, and with an honest belief that their decision served the company’s best interests.3Delaware Department of State. The Delaware Way: Deference to the Business Judgment of Directors Who Act Loyally and Carefully When the rule applies, courts will not substitute their judgment for the board’s, even if the decision proved costly.
To overcome the presumption, a plaintiff must show that the directors had a disqualifying conflict of interest, acted in bad faith, or were grossly negligent in their process.3Delaware Department of State. The Delaware Way: Deference to the Business Judgment of Directors Who Act Loyally and Carefully If the plaintiff succeeds, the burden shifts and directors must prove the transaction was entirely fair to the corporation. Most duty-of-care litigation is won or lost right here. If the business judgment rule holds, the case is effectively over.
When the Defense Fails: Smith v. Van Gorkom
The best-known example of a board breaking through the rule is Smith v. Van Gorkom, a 1985 Delaware Supreme Court decision. The Trans Union Corporation board approved a cash-out merger at $55 per share after two hours of deliberation. The directors had received no prior notice of the proposal, reviewed no written documentation, obtained no independent valuation, and relied entirely on an oral summary from the CEO, who had personally set the price to make a leveraged buyout feasible.4Justia Law. Smith v. Van Gorkom
The court held the directors grossly negligent. They had not informed themselves about the company’s intrinsic value, had not questioned the CEO’s price, and had approved the deal without any crisis to excuse the speed. The court stated that the business judgment rule does not protect “an unintelligent or unadvised judgment.”4Justia Law. Smith v. Van Gorkom The case is still the standard cautionary tale: no matter how experienced you are, skipping the homework before a major decision can cost you personally.
Exculpation Clauses
The fallout from Van Gorkom produced a direct legislative response. Delaware amended its corporate statute to let companies include a charter provision eliminating personal monetary liability for directors who breach the duty of care.5Delaware Code Online. Delaware Code Title 8, Chapter 1, Subchapter I Most states followed. Today the vast majority of public corporations include an exculpation clause, which means that even if a court finds a duty-of-care breach, the directors owe nothing out of pocket.
These clauses have hard limits. They cannot eliminate liability for breaches of the duty of loyalty, acts or omissions not in good faith, intentional misconduct, knowing violations of law, or transactions where the director received an improper personal benefit.5Delaware Code Online. Delaware Code Title 8, Chapter 1, Subchapter I In 2022, Delaware extended exculpation eligibility to certain senior officers, including the CEO, CFO, general counsel, controller, and other executives identified in public filings. That extension carries an added restriction: officers cannot be exculpated for claims brought by the corporation itself or through derivative suits. The protection is not automatic. It applies only if the corporation has actually adopted the provision in its charter.
Indemnification and D&O Insurance
Beyond exculpation, corporations can reimburse directors for legal costs through indemnification. Corporate statutes distinguish mandatory from permissive indemnification. Mandatory indemnification kicks in automatically when a director successfully defends against a lawsuit on the merits. Permissive indemnification gives the corporation discretion to cover legal expenses, settlements, and judgments for directors who acted in good faith and reasonably believed their conduct served the company’s interests.1Delaware Code Online. Delaware Code Title 8, Chapter 1, Subchapter IV Many corporations make indemnification mandatory for all directors and officers through their bylaws, removing the board’s discretion to deny it.
Directors and officers liability insurance adds another layer. A typical D&O policy pays individual directors directly when the company cannot or will not indemnify them, such as during an insolvency. A separate component reimburses the company for indemnification costs it has paid. For publicly traded companies, D&O policies often also cover the corporation directly when securities claims are brought against it. Between exculpation, indemnification, and insurance, a director’s actual out-of-pocket exposure for duty-of-care claims is, in most situations, minimal.
How Duty of Care Claims Get Brought
When directors harm the company through a breach of fiduciary duty, the corporation itself owns the legal claim. Shareholders who want to pursue it must file a derivative lawsuit on the corporation’s behalf, and any monetary recovery goes to the company rather than to the shareholder who filed.
Before filing, shareholders face a procedural hurdle. They must either formally demand that the board take corrective action or show that a demand would be futile because a majority of directors are conflicted or face personal liability from the challenged conduct. Making a demand is risky, because courts treat it as an implicit admission that the board can impartially evaluate the request. If the board then refuses to act, the shareholder faces a steep uphill fight to challenge that refusal. Most derivative suits therefore proceed on a demand-futility theory.
Derivative litigation is slow, expensive, and hard to win, especially for pure duty-of-care claims where directors are protected by both the business judgment rule and an exculpation clause. The mechanism still matters. Its existence shapes board behavior and pushes companies to build the compliance systems the Caremark line of cases expects.
How the Duty of Care Differs From the Duty of Loyalty
The duty of care is one of two core fiduciary obligations in corporate law. The other is the duty of loyalty, which prohibits directors from putting personal interests ahead of the company’s. A loyalty violation involves self-dealing, conflicts of interest, or diverting corporate opportunities for personal gain. A care violation involves failing to pay adequate attention or making decisions without adequate information.
The distinction matters because the protective mechanisms above shield directors from care-based claims but explicitly exclude loyalty violations. If a director approves a merger without reading the financials, that’s a care problem, and exculpation and the business judgment rule will usually resolve it. If a director steers a contract to a company owned by their spouse, that’s a loyalty problem, and those protections largely disappear. Anyone assessing personal exposure should keep the two categories separate from the start.